• Azithromycin in Bacterial Infection Research: Protocols & Pi

  2026-07-02

  Azithromycin stands out as a macrolide antibiotic for advanced bacterial infection and resistance studies, offering robust experimental flexibility. This guide delivers actionable protocols, troubleshooting insights, and a nuanced perspective on resistance trends, with workflows backed by recent peer-reviewed research.

• MLKL-Induced Lysosomal Permeabilization Drives Necroptosis v

  2026-07-02

  The referenced study elucidates how MLKL polymerization triggers lysosomal membrane permeabilization (LMP), leading to the release of cathepsin B and promoting necroptosis. These findings clarify the mechanistic link between lysosomal enzyme release and regulated cell death, opening new avenues for targeted cell death modulation in disease models.

• Sulfo-NHS-SS-Biotin: Precision Protein Labeling for Affinity

  2026-07-01

  Sulfo-NHS-SS-Biotin stands out as a cleavable biotin disulfide N-hydroxysulfosuccinimide ester, enabling highly specific, reversible cell surface protein labeling—ideal for affinity purification and advanced proteomics. Its unique water solubility and disulfide-cleavable spacer arm facilitate streamlined, contamination-minimizing workflows that outpace conventional biotinylation reagents.

• Pregnenolone Carbonitrile: Precision Control of Hepatic and

  2026-07-01

  Explore how Pregnenolone Carbonitrile enables precise, differential regulation of cytochrome P450 enzymes in the liver and brain. Uncover unique mechanisms—beyond classical PXR activation—that inform advanced hepatic detoxification studies and neuroprotection research.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO): Pract

  2026-06-30

  This EDTA-free Protease Inhibitor Cocktail prevents artifactual protein degradation during extraction and analysis, supporting workflows that require divalent cation compatibility such as phosphorylation studies and kinase assays. It should not be used in protocols requiring EDTA-mediated chelation or those incompatible with DMSO-based solutions.

• USP42 Promotes Breast Cancer by Suppressing JNK/p38 Apoptosi

  2026-06-30

  The referenced study identifies USP42 as a key promoter of breast cancer progression by inhibiting JNK/p38-mediated apoptosis. These findings highlight the deubiquitinating enzyme's mechanistic contribution to tumor growth and its potential value as a therapeutic target.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetics

  2026-06-29

  This study introduces a streamlined protocol for generating human iPSC-derived intestinal organoids capable of long-term propagation, differentiation, and functional assessment of drug metabolism. The model addresses key limitations of existing in vitro systems, offering improved physiological relevance for pharmacokinetic research and oral drug evaluation.

• Palonosetron Hydrochloride in CINV: Innovation and Clinical

  2026-06-29

  Ruhlmann and Herrstedt's review evaluates palonosetron hydrochloride as a next-generation 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting (CINV). The paper examines its pharmacological distinctions, clinical efficacy—particularly in delayed-phase emesis—and its positioning relative to earlier antiemetics, providing evidence-driven guidance for oncological supportive care.

• AZD8055: Technical Use Guidance for mTOR Pathway Inhibition

  2026-06-28

  AZD8055 is a potent, selective ATP-competitive mTOR inhibitor designed for preclinical studies dissecting mTORC1 and mTORC2 signaling in cancer and metabolic research. It is not recommended for investigations seeking clinical efficacy endpoints due to minimal translation in late-phase trials. Researchers should follow strict solubilization and workflow guidelines to ensure reproducible results.

• ATM Inhibition and Fenofibrate Synergy in HGSOC Cells

  2026-06-27

  This study demonstrates that inhibiting ATM kinase synergizes with fenofibrate, a metabolic modulator, to induce senescence in high grade serous ovarian cancer (HGSOC) cells. These findings highlight a novel vulnerability in HR-proficient HGSOC and suggest new therapeutic strategies beyond current DNA repair-targeted therapies.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-06-26

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed for high-resolution protein and peptide separation in the 1–10 kDa range, addressing a limitation of standard Tris-glycine SDS-PAGE methods. This kit is intended for research use only and is not suitable for diagnostic or clinical workflows.

• Losartan: Benchmark Angiotensin II Receptor Antagonist for H

  2026-06-26

  Losartan is a selective angiotensin II receptor antagonist widely used to study hypertension and vascular biology. Its high-affinity AT1 receptor blockade and reliable in vitro/in vivo profiles make it a reference compound for dissecting angiotensin II signaling mechanisms. Product benchmarks from APExBIO and peer-reviewed studies confirm its reproducible potency and suitability for cardiovascular research.

• Optimized NIR-II Liposomal Nanoprobes for High-Resolution An

  2026-06-25

  Yu et al. present a rationally engineered NIR-II fluorescent liposomal nanosystem, achieving maximized fluorescence performance and prolonged vascular imaging in vivo. Their systematic analysis of phospholipid charge and dye loading establishes new design principles for high-sensitivity deep tissue imaging.

• Octenidine Dihydrochloride: Advanced Antimicrobial Workflows

  2026-06-25

  Octenidine dihydrochloride sets the standard for research-grade antiseptic compounds, offering robust membrane-disrupting efficacy and high solubility for laboratory workflows. Explore protocol enhancements, comparative innovations, and troubleshooting strategies rooted in the latest gemini QAC discoveries.

• Forsythoside E: Applied PKM2 Inhibition in Macrophage Assays

  2026-06-24

  Forsythoside E, a phenolic acid glycoside from Forsythia suspensa, offers researchers a uniquely selective tool for modulating PKM2-STAT3 signaling and driving macrophage M2 polarization. This article details optimized workflows, protocol parameters, and troubleshooting strategies to maximize reproducibility in sepsis-induced liver injury and immunometabolic research.

15352 records 1/1024 page Next 12345 下5页 Last page